l-carnitine neuropathy studies L-Carnitine | CAM Cancer
Description
doi: 10.1002/oby.22873, PMID: [DOI] [PubMed] [Google Scholar] 27.Kon K, Ikejima K, Morinaga M, Kusama H, Arai K, Aoyama T, et al
15.1 +/-9.8% (placebo and L-carnitine)
[DOI] [PubMed] [Google Scholar] 162.Chung S.-Y., Moriyama T., Uezu E., Uezu K., Hirata R., Yohena N., Masuda Y., Kokubu Y., Yamamoto S
doi: 10.1515/hmbci-2018-0012 82 NieXWeiXMaHFanLChenWD
